The Industry Standard: Intelligence for the Information Economy

  September 5, 2001
  NEWS & ANALYSIS
   Headlines
   Money & Markets
   Tech & Telecom
   Media & Marketing
   Metrics & Stats
   Policy & Politics
  SEARCH
   
  advanced search
  SERVICES
   Company Index
   Newsletters
   Wireless
  PRINT EDITION
   Read the Magazine

Home > Company Index > Drugs > Biotechnology-Medicine > Collateral Therapeutics, Inc.

Collateral Therapeutics, Inc.
Nasdaq: CLTX
Change
symbol:
     
 PROFILE
Collateral Therapeutics develops gene therapy products for the treatment of various cardiovascular diseases as an alternative to such invasive therapies as coronary bypass surgery and angioplasty. Its lead drug candidate is Generx, which promotes angiogenesis (the growth of new blood vessels) in patients with coronary artery disease. The company has teamed with Schering AG to develop and, pending regulatory approval, market the drug. Collateral Therapeutics is also developing drugs that target peripheral vascular disease, congestive heart failure, and ischemic heart disease. It has licensed technology from the University of California and New York University, among others.

 COMPETITION
GenVec, Inc. (GNVC)
Oxford BioMedica plc (OXB)
Vasomedical, Inc. (VASO)

 STOCK ANALYSIS
 View by:
 Day 
 Day 
 Month 
 Month 
 Year 
 Year 
FURTHER ANALYSIS
• Advanced Charting
• Deals

 FINANCIAL OVERVIEW
Fiscal Year-End: December
2000 Sales (mil.): 2.00
1-Yr. Sales Growth: (68.8)%
Employees: 66
Revenue per employee: $30,303.03

 KEY PEOPLE
• Jack W. Reich
    CEO
• Christopher J. Reinhard
    CFO

 CONTACT INFO
11622 El Camino Real
San Diego, CA 92130
US
Phone: 858-794-3400
Fax: 858-794-3440
Online: Web Site

Company Data   News, quotes & more       

Hoovers Online   Hoover's Company Capsule
Copyright © 2001, Hoover's Inc. Austin, Texas.
For changes and updates, contact Hoover's directly.


ADVERTISEMENT
FEATURED LINKS
Home |  Customer Service |  About Us
Australia |  Brazil |  China |  Korea |  Norway |  Poland |  Sweden |  Taiwan

Copyright ©2001 Standard Media International. Privacy Policy
Stock data provided by Stockpoint and its data suppliers. Copyright © 1995-2001